<?xml version="1.0" encoding="UTF-8"?>
<p>Outcomes and clinical trajectories in the decision-tree-identified clusters were compared. Patients in Cluster 2, a sclerotic phenotype with 
 <bold>▲</bold>Joint
 <sup>+7</sup>, Fascia
 <sup>+5</sup>, Sclerosis
 <sup>+4</sup>, 
 <bold>▼</bold> Mouth
 <sup>−5</sup>, Liver
 <sup>−10</sup>, accounting for 10% of patients, had a significantly longer time from stem cell transplantation to chronic GvHD onset (log-rank: 
 <italic>P</italic>&lt;0.0001) (
 <xref ref-type="fig" rid="f5-1040189">Figure 5</xref>).
</p>
